	English [member]
Start Date	2022-07-01	2021-07-01
End Date	2022-09-30	2021-09-30
Filing information [line items]
Disclosure of entity information [abstract]
Name of reporting entity	Malath Cooperative Insurance Co.
Company symbol code\| ISIN code	8020 \| SA000A0MJ2J4
Sector\| Industry group	Financials \| Insurance
Disclosure of document information [abstract]
Whether entity wants to report opening statement of financial position	No
Period covered by financial statements	Quarter 3
Reporting period start date	2022-07-01	2021-07-01
Reporting period end date	2022-09-30	2021-09-30
Description of nature of financial statements	Consolidated
Status of financial statements	Reviewed
Description of presentation currency	Saudi Arabia, Riyals
Level of rounding used in financial statements	Thousands

	Primary auditor [member]	Second primary auditor [member]
	English [member]	English [member]
Start Date	2022-07-01	2022-07-01
End Date	2022-09-30	2022-09-30
Auditors information [line items]
Details of auditors signing report [abstract]
Name of auditor signing report	Ibrahim Ahmad Albassam	Abdullah Mohammad Al Azem
Registration number of auditor	337	335
Details of audit firm [abstract]
Name of audit firm	Al-Bassam & Co. Allied Accountants.	Al Azem, Al Sudairy, Al Shaikh & Partners
Registration number of audit firm	337	335
Contact number of audit firm	011 206 5333	011 217 5000
Address of audit firm	P. O. Box 69658 Riyadh 11557	P. O. Box 10504Riyadh 11443

	English [member]
Start Date	2022-07-01
End Date	2022-09-30
Auditors report [line items]
Disclosures of auditors report [text block]	We have reviewed the accompanying interim condensed statement of financial position of Malath Cooperative Insurance Company (the “Company”) as at 30 September 2022 and the related interim condensed statements of income and other comprehensive income for the three month and nine month periods then ended and the interim condensed statements of changes in equity and cash flows for the nine month period ended, and a summary of significant accounting policies and other explanatory notes (the “interim condensed financial statements”). Management is responsible for the preparation and presentation of these interim condensed financial statements in accordance with International Accounting Standard 34 - “Interim Financial Reporting” (“IAS 34”) that is endorsed in the Kingdom of Saudi Arabia. Our responsibility is to express a conclusion on these interim condensed financial statements based on our review.
Contents of auditors report [abstract]
Nature of auditors opinion	Unmodified opinion
Auditors opinion	Based on our review, nothing has come to our attention that causes us to believe that the accompanying interim condensed financial statements is not prepared, in all material respects, in accordance with IAS 34 that is endorsed in the Kingdom of Saudi Arabia.
Date of signing audit report by auditor	2022-11-08

Start Date	2022-01-01	2021-01-01	2021-01-01
End Date	2022-09-30	2021-12-31	2021-09-30
Statement of financial position [abstract]
Assets [abstract]
Insurance/ takaful operations assets [abstract]
Property and equipment, net, insurance/ takaful operations assets	4,007	4,846	4,897
Investments held-to-maturity, insurance/ takaful operations assets	14,900	10,000	10,000
Deferred policy acquisition costs	30,539	25,618	30,391
Reinsurers/ retakaful share of unearned premiums/ contributions	25,484	14,487	19,988
Prepayments and other assets, insurance/ takaful operations assets	68,432	53,932	58,908
Premiums/ insurance receivables/takaful contributions receivable, net	297,664	218,884	329,939
Reinsurers/ retakaful share of outstanding claims/ benefits, net	124,555	90,130	107,790
Time (Murabaha) deposits, insurance/ takaful operations assets	171,319	129,113	139,398
Deferred excess of loss premiums	2,222	83	83
Available-for-sale investments, insurance/ takaful operations assets	57,784	61,498	62,169
Cash and cash equivalents, insurance/ takaful operations assets	209,157	207,819	157,971
Reinsurance share of IBNR Claims net	10,740	20,802
Total insurance/ takaful operations assets	1,016,803	837,212	921,534
Shareholders assets [abstract]
Investments held-to-maturity, shareholders assets	7,844	9,724	9,574
Statutory deposit	75,000	75,000	75,000
Prepayments and other assets, shareholders assets	1,333	2,547	14,796
Time (Murabaha) deposits, shareholders assets	75,601	0	100,000
Accrued investment income	10,587	10,167
Available-for-sale investments, shareholders assets	103,410	100,128	108,431
Due from insurance/ takaful operations assets	-5,102	-58,804	-57,643
Cash and cash equivalents, shareholders assets	96,401	271,562	196,783
Investments in associates	13,240	0	0
Total shareholders assets	378,314	410,324	446,941
Total assets	1,395,117	1,247,536	1,368,475
Liabilities and equity [abstract]
Insurance/ takaful operations liabilities and surplus (deficit) [abstract]
Insurance/ takaful operations liabilities [abstract]
Gross unearned premiums/ contributions	454,907	427,085	489,932
Unearned commission income	5,789	3,488	4,654
Employees end of service benefits, insurance/ takaful operations liabilities	19,711	20,154
Surplus distribution payable	1,008	1,008	1,008
Due to shareholders operations	-5,102	-58,804	-57,643
Due to related parties, insurance/ takaful operations liabilities		2	2
Reinsurers/ retakaful balance payable	48,225	25,809	24,085
Gross outstanding claims/ benefits including IBNR payable	330,348	268,659	249,517
Other technical reserves	16,006	32,844	45,702
Accrued expenses payable, insurance/ takaful operations liabilities	134,018	126,255	171,196
Other liabilities, insurance/ takaful operations	18,814
Total insurance/ takaful operations liabilities	1,023,724	846,500	928,453
Total insurance/ takaful operations liabilities and surplus (deficit)	1,023,724	846,500	928,453
Shareholders liabilities and equity [abstract]
Shareholders liabilities [abstract]
Zakat payable	22,007	17,252	16,134
Accrued expenses payable, shareholders liabilities	539	2,041	1,816
Other liabilities, shareholders liabilities			10,048
Accrued commission income payable to SAMA	10,587	10,167
Total shareholders liabilities	33,133	29,460	27,998
Shareholders equity [abstract]
Equity attributable to owners of parent [abstract]
Share capital	500,000	500,000	500,000
Statutory reserve	2,131	2,131	2,131
Fair value reserve on investments, shareholders equity	391	529	3,290
Retained earnings (accumulated losses)	-153,014	-120,408	-85,801
Other reserves	-11,248	-10,676	-7,596
Total equity attributable to owners of parent	338,260	371,576	412,024
Total equity attributable to equity holders of company	338,260	371,576	412,024
Total shareholders liabilities and equity	371,393	401,036	440,022
Total insurance/ takaful operations liabilities, surplus (deficit) and shareholders liabilities and equity	1,395,117	1,247,536	1,368,475

Start Date	2022-07-01	2021-07-01	2022-01-01	2021-01-01
End Date	2022-09-30	2021-09-30	2022-09-30	2021-09-30
Statement of insurance/ takaful operations [abstract]
Statement of insurance/ takaful operations and accumulated surplus (deficit) [abstract]
Income from insurance/ takaful operations [abstract]
Net premiums/ contributions earned [abstract]
Net premiums/ contributions written [abstract]
Gross premiums/ contributions written	261,920	284,962	745,819	771,197
Excess of loss expense	7,254	1,994	11,285	10,305
Reinsurance/ retakaful premiums ceded	13,363	8,513	57,378	43,654
Net premiums/ contributions written	241,303	274,455	677,156	717,238
Changes in unearned premiums/ contributions	28,149	70,190	16,825	156,022
Net premiums/ contributions earned	213,154	204,265	660,331	561,216
Reinsurance/ retakaful commissions	2,848	2,614	9,921	9,401
Investment income from insurance/ takaful operations, net	5,162	2,390	12,141	8,748
Fees and other income from insurance/ takaful operations	10,838	435	12,688	932
Total income from insurance/ takaful operations	232,002	209,704	695,081	580,297
Cost and expenses [abstract]
Net claims/ benefits incurred [abstract]
Net claims/ benefits paid [abstract]
Gross claims/ benefits paid	175,412	172,667	559,737	531,616
Reinsurance/ retakaful share of gross claims/ benefits paid	3,695	4,749	7,819	16,132
Net claims/ benefits paid	171,717	167,918	551,918	515,484
Changes in outstanding claims/ benefits including IBNR	10,811	-214	24,709	-38,746
Changes in other technical reserves	-5,362	22,403	-4,220	5,787
Net claims/ benefits incurred	177,166	190,107	572,407	482,525
Policy acquisition costs	20,928	17,996	53,732	47,555
General and administrative expenses, insurance/ takaful operations	28,809	30,485	92,419	86,114
Other underwriting income	148	4	234	4,662
Other underwriting expenses	5,646	7,813	22,923	13,492
Other cost and expenses	2,350	1,180	4,510	10,106
Total cost and expenses	234,751	247,577	745,757	635,130
Surplus (deficit) for period from insurance/ takaful operations	-2,749	-37,873	-50,676	-54,833
Shareholders appropriation from insurance/ takaful operations surplus (deficit)	-2,749	-37,873	-50,676	-54,833
Net result for period from insurance/ takaful operations after shareholders appropriation	0	0	0	0
Policyholders share of accumulated surplus, at end of period	0	0	0	0

Start Date	2022-07-01	2021-07-01	2022-01-01	2021-01-01
End Date	2022-09-30	2021-09-30	2022-09-30	2021-09-30
Statement of shareholders operations [abstract]
Profit (loss) [abstract]
Income (loss) from continuing operations [abstract]
Shareholders appropriation of surplus (deficit) transferred from insurance/ takaful operations	-2,749	-37,873	-50,676	-54,833
Revenue [abstract]
Investment income	4,048	4,740	28,372	12,843
Other income			0	5,195
Total revenue	4,048	4,740	28,372	18,038
Expenses [abstract]
General and administrative expenses, shareholders operations	304	292	1,637	4,525
Total expenses	304	292	1,637	4,525
Income (loss) from continuing operations before zakat and income tax	995	-33,425	-23,941	-41,320
Zakat expenses on continuing operations for period	2,165	3,244.25	8,665	9,733
Profit (loss) from continuing operations	-1,170	-36,669.25	-32,606	-51,053
Profit (loss) for the period	-1,170	-36,669.25	-32,606	-51,053
Profit (loss), attributable to [abstract]
Profit (loss), attributable to saudi shareholders of company	-1,170	-36,669.25	-32,606	-51,053
Earnings per share [abstract]
Basic earnings (loss) per share [abstract]
Basic earnings (loss) per share from continuing operations	-0.0234	-0.7334	-0.6521	-1.0211
Total basic earnings (loss) per share	-0.0234	-0.7334	-0.6521	-1.0211
Weighted average number of equity shares outstanding	50000	50000	50000	50000

Start Date	2022-07-01	2021-07-01	2022-01-01	2021-01-01
End Date	2022-09-30	2021-09-30	2022-09-30	2021-09-30
Statement of other comprehensive income, before tax [abstract]
Net result for period from insurance/ takaful operations after shareholders appropriation	0	0	0	0
Other comprehensive income [abstract]
Components of other comprehensive income that will be reclassified to profit or loss [abstract]
Available-for-sale financial assets [abstract]
Gains (losses) on remeasuring available-for-sale financial assets	726	827	2,367	677
Total other comprehensive income (loss), available-for-sale financial assets	726	827	2,367	677
Total other comprehensive income (loss), that will be reclassified to profit or loss	726	827	2,367	677
Total other comprehensive income (loss)	726	827	2,367	677
Total comprehensive income (loss) for period	726	827	2,367	677

Start Date	2022-07-01	2021-07-01	2022-01-01	2021-01-01
End Date	2022-09-30	2021-09-30	2022-09-30	2021-09-30
Statement of other comprehensive income, before tax [abstract]
Statement of comprehensive income [abstract]
Profit (loss) for the period	-1,170	-36,669.25	-32,606	-51,053
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss [abstract]
Other comprehensive gains (losses) that will not be reclassified to profit or loss			-572
Total other comprehensive income that will not be reclassified to profit or loss			-572
Components of other comprehensive income that will be reclassified to profit or loss [abstract]
Available-for-sale financial assets [abstract]
Gains (losses) on remeasuring available-for-sale financial assets	765	2,130	-2,505	1,940
Total other comprehensive income (loss), available-for-sale financial assets	765	2,130	-2,505	1,940
Total other comprehensive income (loss), that will be reclassified to profit or loss	765	2,130	-2,505	1,940
Total other comprehensive income (loss)	765	2,130	-3,077	1,940
Total comprehensive income (loss) for period	-405	-34,539.25	-35,683	-49,113
Total comprehensive income (loss) attributable to [abstract]
Total comprehensive income (loss), attributable to saudi shareholders of company	-405	-34,539.25	-35,683	-49,113

Start Date	2022-01-01	2021-01-01
End Date	2022-09-30	2021-09-30
Statement of cash flows, indirect method [abstract]
Statement of cash flows, insurance/ takaful operations [abstract]
Cash flows from (used in) operating activities, insurance/ takaful operations [abstract]
Net result for period from insurance/ takaful operations after shareholders appropriation	0	0
Adjustments to reconcile net income to net cash from insurance/ takaful operations after shareholders appropriation
Adjustments for depreciation, insurance/ takaful operations cash flow	1,447	1,383
Adjustments for employees end of service benefits	2,965	3,607
Adjustments for allowance for doubtful receivables	4,510	10,106
Adjustments for (gains) losses on disposal of available-for-sale investments	-1,364
Total adjustments to reconcile net income to net cash from insurance/ takaful operations after shareholders appropriation	7,558	15,096
Changes in operating assets and liabilities [abstract]
Adjustments for decrease (increase) in premium receivables, net	-83,290	-139,821
Adjustments for decrease (increase) in prepayments and other assets	-14,500	-32,569
Adjustments for increase (decrease) in outstanding claims including IBNR	61,689	-42,725
Adjustments for increase (decrease) in reinsurers/ retakaful balance payable	22,416	17,245
Adjustments for increase (decrease) in retrocession balance payable	0	-2,409
Adjustments for increase (decrease) in accrued expenses and other liabilities	26,575	29,812
Adjustments for decrease (increase) in reinsurers/ retakaful share of outstanding claims, net	-24,363	7,365
Adjustments for decrease (increase) in deferred policy acquisition costs	-4,921	-10,274
Adjustments for decrease (increase) in deferred excess of loss expense	-2,139	-83
Adjustments for decrease (increase) in unearned commission income	2,301	653
Adjustments for movement in gross unearned premiums/ contributions	27,822	158,958
Adjustments for reinsurance/ retakaful share of unearned premiums/ contributions	-10,997	-2,937
Adjustment for changes in other technical reserves	-97	-100
Adjustment for changes in other reserves	-16,741	2,501
Adjustments for other changes in operating assets and liabilities, insurance/ takaful operations cash flow	-3,408	-2,867
Total changes in operating assets and liabilities	-19,653	-17,251
Net cash flows from (used in) insurance/ takaful operations	-12,095	-2,155
Other inflows (outflows) of cash classified as operating activities, insurance/ takaful operations cash flow	0	-4,657
Net cash flows from (used in) operating activities, insurance/ takaful operations	-12,095	-6,812
Cash flows from (used in) investing activities, insurance/ takaful operations [abstract]
Time (Murabaha) deposits, insurance/ takaful operations cash flow	-42,206	25,886
Proceeds from sales of available-for-sale investments, insurance/ takaful operations cash flow	7,445
Purchase of available-for-sale investments, insurance/ takaful operations cash flow	0	-3,881
Purchase of held-to-maturity investments, insurance/ takaful operations cash flow	4,900
Purchase of property and equipment, insurance/ takaful operations cash flow	608	4,179
Other inflows (outflows) of cash classified as investing activities, insurance/ takaful operations cash flow		-11,397
Net cash flows from (used in) investing activities, insurance/ takaful operations	-40,269	14,191
Cash flows from (used in) financing activities, insurance/ takaful operations [abstract]
Adjustments for decrease (increase) in due from shareholders operations	53,702	-52,874
Net cash flows from (used in) financing activities, insurance/ takaful operations	53,702	-52,874
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	1,338	-45,495
Net increase (decrease) in cash and cash equivalents	1,338	-45,495
Cash and cash equivalents at beginning of period	207,819	203,466
Cash and cash equivalents at end of period	209,157	157,971

	English [member]	Note No.
Start Date	2022-07-01	2021-07-01
End Date	2022-09-30	2021-09-30
Disclosure of other non-cash information [line items]
Disclosure of other non-cash information, insurance/ takaful operations [text block]	Change in fair value of available-for-sale investments 2,367 (2,505) (138)

Start Date	2022-01-01	2021-01-01
End Date	2022-09-30	2021-09-30
Statement of cash flows, indirect method [abstract]
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Net profit (loss) for period [abstract]
Income (loss) from continuing operations before zakat and income tax	-23,941	-41,320
Net profit (loss) for period (before zakat expenses and income tax)	-23,941	-41,320
Adjustments to reconcile profit (loss) [abstract]
Adjustments for realised loss (gain) on available-for-sale investments, shareholders cash flow	-8,791	-3,098
Adjustments for impairment (reversal of impairment) charges for investments, shareholders cash flow		0
Adjustment for loss (income) from joint ventures and associates, shareholders cash flow	-11,890
Other adjustments for non-cash items	0	-5,388
Total adjustments to reconcile profit (loss)	-20,681	-8,486
Changes in operating assets and liabilities [abstract]
Adjustments for increase (decrease) in accrued expenses and other liabilities, shareholders cash flow	-1,501	379
Adjustments for decrease (increase) in due from insurance/ takaful operations	-53,702	52,874
Adjustments for decrease (increase) in prepayments and other assets, shareholders assets	1,214	-4,298
Total changes in operating assets and liabilities	-53,989	48,955
Net cash flows from (used in) operations	-98,611	-851
Zakat expenses	3,910	8,585
Net cash flows from (used in) operating activities	-102,521	-9,436
Cash flows from (used in) investing activities [abstract]
Purchase of available-for-sale investments	12,134	61,131
Proceeds from disposal of available-for-sale investments	13,215	20,320
Purchase of held-to-maturity investments	0	9,574
Proceeds from disposal of held-to-maturity investments	1,880	0
Purchase of term deposits investments	75,601	100,000
Net cash flows from (used in) investing activities	-72,640	-150,385
Cash flows from (used in) financing activities [abstract]
Other inflows (outflows) of cash	0	0
Net cash flows from (used in) financing activities	0	0
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	-175,161	-159,821
Net increase (decrease) in cash and cash equivalents	-175,161	-159,821
Cash and cash equivalents at beginning of period	271,562	356,604
Cash and cash equivalents at end of period	96,401	196,783

	English [member]	Note No.
Start Date	2022-07-01	2021-07-01
End Date	2022-09-30	2021-09-30
Disclosure of other non-cash information [line items]
Disclosure of other non-cash information, shareholders operations [text block]	Commission income on statutory deposit 420 420

[400100] Notes forming part of accounts

	English [member]	Note No.
Start Date	2022-07-01
End Date	2022-09-30
Notes forming part of accounts [line items]
Disclosure of notes and other explanatory information [text block]
Disclosure of general information about reporting entity [abstract]
Disclosure of general information about reporting entity [text block]	1- Organization and principal activities Malath Cooperative Insurance Company (the “Company”) is a Saudi Joint Stock Company established in Riyadh, Kingdom of Saudi Arabia by Royal Decree Number M/60 and incorporated on 21 Rabi Al-Awal 1428H corresponding to 9 April 2007 under Commercial Registration No. 1010231787. The Company’s head office is situated at Mohammad Bin Abdelaziz Street, P.O. Box 99763, Riyadh 11625, and Kingdom of Saudi Arabia. The objectives of the Company are to engage in providing insurance and related services in accordance with its by-laws and the applicable regulations in the Kingdom of Saudi Arabia (KSA).
Disclosure of basis of preparation of financial statements [text block]	2 BASIS OF PREPARATION (a) Basis of presentation and measurement These interim condensed financial information (interim condensed financial statements) of the Company as at and for the period ended 30 September 2022 have been prepared in accordance with International Accounting Standard 34 Interim Financial Reporting (“IAS 34”), as endorsed in the Kingdom of Saudi Arabia by Saudi Organization for Chartered and professional Accountants (SOCPA). These interim condensed financial statements are prepared under the going concern concept and the historical cost convention, except for the measurement at fair value of available-for-sale investments and employees' end of service benefits measured at present value of future obligations using projected unit credit method. The Company’s interim condensed statement of financial position is not presented using a current/non-current classification. However, the following balances would generally be classified as non-current: Available-for-sale investments, Property and equipment, Statutory deposit, Accrued income on statutory deposit, Employees' end-of-service benefits and Accrued commission income payable to Saudi Central Bank ("SAMA"). All other financial statement line items balances would generally be classified as current. The Company presents its interim condensed statement of financial position in order of liquidity. As required by the law on Supervision of Co-operative Insurance Companies, the Company maintains separate books of accounts for Insurance Operations and Shareholders’ Operations and presents the interim condensed financial statements accordingly (Note 19). Assets, liabilities, revenues and expenses clearly attributable to either activity are recorded in the respective accounts. The basis of allocation of expenses from joint operations is determined and approved by the management and the Board of Directors. 'In preparing the Company-level interim condensed financial statements in compliance with IFRSs as endorsed in KSA, the balances and transactions of the insurance operations are amalgamated and combined with those of the shareholders’ operations. Inter-operation balances and transactions are eliminated in full during amalgamation. The accounting policies adopted for the insurance operations and shareholders operations are uniform for like transactions and events in similar circumstances. The interim condensed statement of financial position, interim condensed statements of income, comprehensive income and cash flows of the insurance operations and shareholders operations which are presented in Note 19 of the interim condensed financial statements have been provided as supplementary financial information to comply with the requirements of the guidelines issued by SAMA implementing regulations and is not required under IFRSs as endorsed in KSA. SAMA implementing regulations requires the clear segregation of the assets, liabilities, income and expenses of the insurance operations and the shareholders operations. Accordingly, the interim condensed statements of financial position, interim condensed statements of income, interim condensed statement of comprehensive income and interim condensed statement of cash flows prepared for the insurance operations and shareholders operations as referred to above, reflect only the assets, liabilities, income, expenses and comprehensive gains or losses of the respective operations. 2 BASIS OF PREPARATION (continued) (b) Functional and presentation currency These interim condensed financial statements have been presented in Saudi Riyals (SR), which is also the functional currency of the Company. All financial information has been rounded off to the nearest thousand, unless otherwise stated. (c) Critical accounting judgments, estimates and assumptions The preparation of the interim condensed financial statements requires the use of estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates and judgments are based on management’s best knowledge of current events and actions, actual results ultimately may differ from those estimates. Estimates and judgments are continually evaluated and based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Following are the accounting judgments and estimates that are critical in preparation of these interim condensed financial statements: i) The ultimate liability arising from claims made under insurance contracts The estimation of the ultimate liability arising from claims made under insurance contracts is the Company’s most critical accounting estimate. There are several sources of uncertainty that need to be considered in the estimate of the liability that the Company will ultimately pay for such claims. Estimates are made at the end of the reporting period both for the expected ultimate cost of claim reported and for the expected ultimate costs of Claims Incurred But Not Reported (“IBNR”). Liabilities for unpaid reported claims are estimated using the input of assessments for individual cases reported to the Company. At the end of each reporting period, prior year claim estimates are reassessed for adequacy and changes are made to the provision. The provision for IBNR is an estimation of claims which are expected to be reported subsequent to the date of interim condensed statement of financial position, for which the insured event has occurred prior to the date of interim condensed statement of financial position. The primary technique adopted by management in estimating the cost of notified and IBNR claims, is that of using the past claims settlement trends to predict future claims settlement trends. A range of methods such as Chain Ladder Method, Bornhuetter-Ferguson Method and Expected Loss Ratio Method are used by the actuaries to determine these provisions. The actuary has also used a segmentation approach including analyzing cost per member per year for medical line of business. Underlying these methods are a number of explicit or implicit assumptions relating to the expected settlement amount and settlement patterns of claims. ii) Impairment of available-for-sale investments The Company determines that investments are impaired when there has been a significant or prolonged decline in the fair values of the financial assets below its cost. The determination of what is ‘significant’ or ‘prolonged’ requires judgement. A period of 12 months or longer is considered to be prolonged and a decline of 30% from original cost is considered significant as per Company policy. In making this judgement, the Company evaluates, among other factors, the duration or extent to which the fair value of an investment is less than its cost.
Disclosure of new standards and amendments in standards [text block]	3 SIGNIFICANT ACCOUNTING POLICIES The accounting policies adopted in the preparation of these interim condensed financial statements are consistent with those followed in the preparation of the Company’s annual financial statements for the year ended 31 December 2021, except for the adoption of new standards effective as of 1 January 2022. The Company has not early adopted any standard (interpretation) or amendments that has been issued but which are not yet effective. 11 3 SIGNIFICANT ACCOUNTING POLICIES (continued) a) Amendment to standards and interpretations There are no new standards issued, however, certain amendments to standards and interpretations which are effective from 1 January 2022 and were listed in the Company's annual financial statements of 31 December 2021, but they do not have any impact on the interim condensed financial statements of the Company. b) Standards issued but not yet effective The Company has chosen not to early adopt the amendments and revisions to the IFRSs, which have been published and are mandatory for compliance for the Company with effect from future dates. STANDARD/INTERPRETATION/AMENDMENTS DESCRIPTION EFFECTIVE FROMPERIODS BEGINNING ON OR AFTER THEFOLLOWING DATE IFRS 9 Financial Instruments (refer below) 1-Jan-20 IFRS 17 Insurance Contracts (refer below) 1-Jan-23 a. IFRS 9 - Financial Instruments The implementation of IFRS 9 is expected to result in a significant portion of financial assets currently classified as available-for-sale being re-classified as at fair value through profit or loss or fair value through other comprehensive income (OCI). Credit allowances for financial assets carried at amortized cost and debt securities measured at fair value, with changes in fair value recognized in OCI, are expected to increase due to the introduction of the expected credit loss methodology. The Company is using the exemptions available to insurers to defer the implementation of IFRS 9 until implementation of IFRS 17. The impact of the adoption of IFRS 9 on the Company’s interim condensed financial statements will, to a large extent, have to take into account the interaction with the IFRS 17 "Insurance contracts". At present the Company has not fully assessed the effects of adoption of IFRS 9. b. IFRS 17 - Insurance Contracts Overview This standard has been published in May, 2017. It establishes the principles for the recognition, measurement, presentation and disclosure of insurance contracts and supersedes IFRS 4 – Insurance contracts. The new standard applies to insurance contracts issued, to all reinsurance contracts and to investment contracts with discretionary participating features, provided the entity also issues insurance contracts. It requires to separate the following components from insurance contracts: i- embedded derivatives, if they meet certain specified criteria; ii- distinct investment components; and iii- any promise to transfer distinct goods or non-insurance services. 12 3 SIGNIFICANT ACCOUNTING POLICIES (continued) b. IFRS 17 - Insurance Contracts (continued) Effective date The effective date of IFRS 17 and the deferral of the IFRS 9 temporary exemption in IFRS 4 is currently for reporting periods beginning on or after January 1, 2023. This is a deferral of 2 year compared to the previous date of January 1, 2021. Earlier application is permitted if both IFRS 15 – Revenue from Contracts with Customers and IFRS 9 – Financial Instruments have also been applied. The Company intends to apply the Standard on its effective date. Transition Retrospective application is required. However, if full retrospective application for a group of insurance contracts is impracticable, then the entity is required to choose either a modified retrospective approach or a fair value approach. Impact The Company carried out assessment for ascertaining the impact of the application and implementation of IFRS 17 on results of the financial year 2018. The Company has also undertaken an initial operational impact gap analysis and currently undergoing through detailed operational and financial impact assessment along with working on planning and design phase to enable the Company to establish required system and processes under IFRS 17. Key gaps and their impact noted so far are as follows: Major areas of design phase Summary of progress Governance and control framework The Company has put in place a comprehensive IFRS 17 governance program which includes establishing oversight steering committee for monitoring the progress of implementation and assigning roles and responsibilities to various stakeholders. Operational area The Company has finalzied of designing operational aspects of the design phase which includes establishing comprehensive data policy and data dictionary and architectural designs for various sub-systems. Technical and financial area The Company has completed various policy papers encompassing various technical and financial matters after concluding on policy decisions required under the IFRS 17 standard. The policy decisions are taken after due deliberations among various stakeholders. Assurance plan The Company is working along with its other stakeholders to finalize the assurance plan for transitional and post-implementation periods. 13 3 SIGNIFICANT ACCOUNTING POLICIES (continued) Investments in associates An associate is an entity in which the Company has significant influence (but not control), over financial and operating policies and which is neither a subsidiary nor a joint venture. Investments in associates are carried in the statement of financial position at cost, plus post acquisition changes in the Company’s share of net assets of the associate, less any impairment in the value of individual investments. When the company’s share of losses in an associate equals or exceeds its interest in the associate, including any other unsecured receivables, the Company does not recognize further losses, unless it has incurred legal or constructive obligations or made payments on behalf of the associate. At each reporting date, the Company determines whether there is objective evidence that the investment in associate is impaired. If there is such evidence, the Company calculates the amount of impairment as the difference between the recoverable amount of the associate and its carrying value, and then recognizes the loss in the statement of income, as the case may be At each reporting date, the Company determines whether there is objective evidence that the investment in associate is impaired. If there is such evidence, the Company calculates the amount of impairment as the difference between the recoverable amount of the associate and its carrying value, and then recognises the loss in the consolidated statement of income, as the case may be. On derecognition the difference between the carrying amount of investment in the associate and the fair value of the consideration received is recognized in the statement of income.
Disclosure of summary of significant accounting policies [abstract]
Description of accounting policy for premiums/ contributions and insurance/ reinsurance or takaful/ retakaful balance receivables [text block]	6 PREMIUMS AND REINSURERS' RECEIVABLE - NET Receivables comprise amounts due from the following: 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Policyholders 311,428 233,414Reinsurers 6,562 1,396Insurance companies 16,227 11,581Agents and brokers 11,531 16,067 345,748 262,458Less: Provision for doubtful receivables - insurance (47,772) (43,287)Provision for doubtful receivables - reinsurers (312) (287) (48,084) (43,574) 297,664 218,884 The movement in the provision for doubtful receivables is as follows: 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Balance at the beginning of the period/year 43,574 36,528 Provision made during the period/year 4,510 7,046 Balance at the end of the period/year 48,084 43,574
Disclosure of notes forming part of accounts [abstract]
Disclosure of investments [text block]	5 MURABAHA DEPOSITS 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Insurance operations Murabaha deposits 171,319 129,113 Shareholders' operations Murabaha deposits 75,601 - Total Murabaha deposits 246,920 129,113 Murabaha deposits have an original maturity of more than three months from the date of acquisition and are subject to an average commission rate of 3.32% per annum as at 30 September 2022 (31 December 2021: 1.57% per annum). The carrying amounts disclosed above are not
Disclosure of cash and cash equivalents [text block]	4 CASH AND CASH EQUIVALENTS 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Insurance operations Cash in banks 44,984 37,074 Cash on hand 19 19 Short term Murabaha deposits 164,154 170,726 209,157 207,819 Shareholders' operations Cash in banks 3,448 141,930 Short term Murabaha deposits 92,953 129,632 96,401 271,562 Total cash and cash equivalents 305,558 479,381 Short term Murabaha deposits have original maturity of less than three months from the date of acquisition and are subject to an average commission rate of 4.24% per annum as at 30 September 2022 (31 December 2021: 1.73%). The carrying amounts disclosed above are not materially different from their fair values at the date of the interim condensed statement of financial position. Cash at bank includes an amount of SR 14.5 million (Note 20) (2021: SR 732 thousand) that pertains to the company's share of Inherent Defect Insurance (IDI) portfolio.
Disclosure of zakat [text block]	11 PROVISION FOR ZAKAT a) Zakat payable The movement in zakat payable during the period/year was as follows: 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Balance at beginning of the period/year 17,252 20,374 Charge for the period/year 8,665 12,810 Reversal of zakat provision during the period/year - (5,855)Payments during the period/year (3,910) (10,077)Balance at end of the period/year - 22,007 17,252 b) Status of assessments The Company had filed the Zakat return for the years 2016 to 2020 and received a temporary Zakat certificate. Assessments have been received from ZATCA to date in respect of these years. For the year 2021, the Company has filed the Zakat return before deadline of April 30, 2022 and received temporary Zakat certificate. 19 11 PROVISION FOR ZAKAT (continued) c) Status of appeals (continued) The years from 2016 to 2018: On December 27, 2020, the ZATCA raised its assessments for those years claiming additional zakat liability of Saudi Riyals 3.3 million, then the company has appealed against such assessment within the legally prescribed period. As result, ZATCA has partially accepted the company’s appeal and issued a revised assessment for the company’s favor which resulted an overpaid amount of Saudi Riyals (1.5 million) for the company. However, the company has decided to escalate the case to the GSTC. During August 2022, the Committee for Resolution of Tax Violations and Disputes (“CRTVD”) (which is the first level of the GSTC committees) has issued its verbal decision which resulted an overpaid amount of Saudi Riyals (1.8 million) for the company based on understanding of such verbal decision. Noting that both the company and ZATCA have the right to appeal against such ruling to the Appellate Committee for Tax Violations and Disputes Resolution (“ACTVDR”) (Which is the second and final level of GSTC committees) once issuing the official written ruling by CRTVD which expected to be issued soon. Thus, such CRTVD ruling is not final. The years 2019 & 2020: On September 30, 2021, the Zakat, Tax and Customs Authority ("ZATCA") raised its assessments for those years claiming additional zakat liability of Saudi Riyals 5.2 million, then the company has appealed against such assessment within the legally prescribed period. As result, ZATCA has partially accepted the company’s appeal and issued a revised assessment through which the additional zakat liability has been reduced to Saudi Riyals 4.9 million knowing that the company has already settled along with the appeal an amount of Saudi Riyals 1.3 million which represents 25% of the disputed additional zakat liability as per the original assessment to fulfil the formality conditions of appeal submission stated in the zakat regulations, and the company has escalated its appeal case to the GSTC. During September 2022, CRTVD has issued its verbal decision and reduced the zakat liability to 3.7 million based on understanding of such verbal decision. Noting that both the company and ZATCA have the right to appeal against such ruling to the ACTVDR once issuing the official written ruling by CRTVD which expected to be issued soon. Thus, such CRTVD ruling is not final.
Disclosure of statutory reserve [text block]	14 STATUTORY RESERVE In accordance with the Company’s By-Laws and in compliance with Article 70(2)(g) of the Insurance Implementing Regulations issued by SAMA, the Company is required to allocate 20% of its net income for the year to the statutory reserve until it equals the value of share capital and such transfer is only made at year end. The statutory reserve is not available for distribution to shareholders until liquidation of the Company.
Disclosure of technical reserve for insurance/takaful/reinsurance/retakaful operations [text block]	7 TECHNICAL RESERVES a) Outstanding claims and reserves 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Outstanding claims 118,682 59,549 Claims incurred but not reported (IBNR) 211,666 209,110 Additional premium reserves 11,671 28,412 Other technical reserves 4,335 4,432 346,354 301,503 Reinsurers' share of outstanding claims (124,555) (90,130)Reinsurers' share of claims incurred but not reported (10,740) (20,802) (135,295) (110,932)Net outstanding claims and reserves 211,059 190,571 b) Unearned premiums 30 September (Unaudited) Gross Reinsurers' share Net SR (000) Unearned premiums at beginning of the period 427,085 (14,487) 412,598 Premiums written during the period 745,819 (68,663) 677,156 Premiums earned during the period (717,997) 57,666 (660,331)Unearned premiums at end of the period 454,907 (25,484) 429,423 31 December 2021 (Audited) Gross Reinsurers' share Net SR (000) Unearned premiums at beginning of the year 330,974 (17,051) 313,923 Premiums written during the year 942,107 (64,720) 877,387 Premiums earned during the year (845,996) 67,284 (778,712)Unearned premiums at end of the year 427,085 (14,487) 412,598 c) Unearned reinsurance commission 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Balance at beginning of the period/year 3,488 4,001 Commission received during the period/year 12,222 7,810 Commission earned during the period/year (9,921) (8,323)Balance at end of the period/year 5,789 3,488 7 TECHNICAL RESERVES (continued) d) Deferred policy acquisition costs 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Balance at beginning of the period/year 25,618 20,117 Paid during the period/year 58,653 71,331 Amortized during the period/year (53,732) (65,830)Balance at end of the period/year 30,539 25,618 8 AVAILABLE-FOR-SALE INVESTMENTS 30 September 31 December 2022 2021 (Unaudited) (Audited) SR (000) Insurance operations Quoted Equity shares 187 6,269 Unquoted Funds 52,482 50,114 Equity shares 5,115 5,115 57,784 61,498 Shareholders’ operations Quoted Equity shares 69,341 65,898 Unquoted Funds 31,169 30,430 Equity shares 2,900 3,800 103,410 100,128 Total available for sale investments 161,194 161,626 The fair values of the unquoted mutual funds computed above are based on the latest reported of net assets value as at the reporting date. Unquoted equity shares in shareholders' operations which is carried at cost due to absence of active market or other means of reliably measuring its fair value. An impairment review is performed at each reporting date. During the period ending at September 30, 2022. the investment in Najm insurance services has been reclassified from ‘available for sale investment’ to ‘investment in associates’ (Refer Note 9).
Disclosure of entity's operating segments [text block]	19 SEGMENT INFORMATION Consistent with the Company's internal reporting process, operating segments have been approved by management in respect of the Company's activities, assets and liabilities as stated below. Segment results do not include income from investments, income from Murabaha deposits, other income, general and administrative expenses, and provision for doubtful debts. Segment results do not include commission on short-term Murabaha deposits. Segment assets do not include insurance operations’ cash and cash equivalents, Murabaha deposits, available for sale investments, premium and reinsurers' receivable net, prepayments and other assets and property and equipment. Accordingly, they are included in unallocated assets. Segment liabilities do not include reinsurance balances payable, policyholders claims payable, accrued and other liabilities, accumulated surplus and due to related parties. Accordingly, they are included in unallocated liabilities. These unallocated assets and liabilities (including the related charges for provision for doubtful debts on premiums and reinsurers’ receivable and depreciation on the property and equipment) are not reported to Chief Executive Officer under related segments and are monitored on a centralized basis. 19 SEGMENT INFORMATION (continued) Nine-months period ended 30 September 2022 (Unaudited) Property & Operating segment Medical Motor casualty Total SR (000) Revenues Gross premiums written 415,300 262,257 68,262 745,819 -Individuals 8,299 180,183 48 188,530 -Very small enterprises 3,645 1,184 3 4,832 -Small enterprises 54,321 30,263 1,158 85,742 -Medium enterprises 86,046 12,072 8,735 106,853 -Corporates 262,989 38,555 58,318 359,862 415,300 262,257 68,262 745,819 Reinsurance premiums ceded - Local - - (6,075) (6,075) - International (9) - (51,294) (51,303) (9) - (57,369) (57,378)Excess of loss expenses - Local (1,850) (402) (227) (2,479) - International (1,850) (5,217) (1,739) (8,806) (3,700) (5,619) (1,966) (11,285)Net premiums written 411,591 256,638 8,927 677,156 Movement in unearned premiums, net (81,820) 66,182 (1,187) (16,825)Net premiums earned 329,771 322,820 7,740 660,331 Reinsurance commissions - - 9,921 9,921 Other underwriting income 2,899 97 9,692 12,688 Net revenues 332,670 322,917 27,353 682,940 Underwriting costs and expenses Gross claims paid (189,748) (371,367) 1,378 (559,737)Reinsurers' share of claims paid 1,320 8,274 (1,775) 7,819 Net claims paid (188,428) (363,093) (397) (551,918)Movement in outstanding claims, net (47,625) 22,924 (8) (24,709)Movement in claims incurred but not reported, net (8,748) (4,320) 450 (12,618)Movement in additional premium reserve (1,280) 18,516 (495) 16,741 Movement in other technical reserves (241) (70) 408 97 Net claims incurred (246,322) (326,043) (42) (572,407) Policy acquisition costs (22,584) (23,811) - (7,337) (53,732)Other underwriting expense (196) (22,714) - (13) (22,923)Total underwriting costs and expenses (269,102) (372,568) (7,392) (649,062)Net underwriting income / (cost) 63,568 (49,651) 19,961 33,878 Unallocated revenue 40,747 Unallocated expenses (98,566)Total loss before Zakat for the period (23,941) 24 19 SEGMENT INFORMATION (Continued) Nine-months period ended 30 September 2021 (Unaudited) Property & Operating segment Medical Motor casualty Total SR (000) Revenues Gross premiums written -Individuals 435 245,628 429 246,492 -Very small enterprises 2,588 1,645 40 4,273 -Small enterprises 33,089 17,055 572 50,716 -Medium enterprises 53,991 11,490 4,961 70,442 -Corporates 233,162 121,037 45,075 399,274 323,265 396,855 51,077 771,197 Reinsurance premiums ceded - Local - - (4,012) (4,012) - International (65) - (39,577) (39,642) (65) - (43,589) (43,654)Excess of loss expenses - Local (340) (679) (173) (1,192) - International (410) (7,062) (1,642) (9,113) (750) (7,741) (1,815) (10,305) Net premiums written 322,450 389,114 5,674 717,238 Movement in unearned premiums, net (68,115) (87,656) (251) (156,022)Net premiums earned 254,335 301,458 5,423 561,216 Reinsurance commissions - - 9,401 9,401 Other underwriting income 252 464 216 932 Net revenues 254,587 301,922 15,040 571,549 Underwriting costs and expenses Gross claims paid (210,782) (304,191) (16,643) (531,616)Reinsurers' share of claims paid 1,714 1,696 12,722 16,132 Net claims paid (209,068) (302,495) (3,921) (515,484)Movement in outstanding claims, net 17,282 17,934 3,530 38,746 Movement in IBNR, net 2,664 (6,540) 490 (3,386)Movement in additional premium reserve 6,756 (8,506) (751) (2,501)Movement in other technical reserve 161 (136) 75 100 Net claims incurred (182,205) (299,743) (577) (482,525)Policy acquisition costs (18,196) (22,968) (6,391) (47,555)Other underwriting expense - (13,492) - (13,492)Total underwriting costs and expenses (200,401) (336,203) (6,968) (543,572) Net underwriting income / (cost) 54,186 (34,281) 8,072 27,977 Unallocated revenue 31,448 Unallocated expenses (100,745)Total loss before Zakat for the period (41,320) 25 19 SEGMENT INFORMATION (continued) As at 30 September 2022 (Unaudited) Property & Operating segment Medical Motor casualty Total SR (000) Assets Reinsurer's share of unearned premiums 6 - 25,478 25,484 Reinsurers' share of outstanding claims 3,138 17,612 103,805 124,555 Reinsurers' share of claims incurred but not reported - - 10,740 10,740 Deferred policy acquisition costs 15,882 11,026 3,631 30,539 Segment assets 19,026 28,638 143,654 191,318 Unallocated assets 1,208,901 Total assets 1,400,219 Liabilities Unearned premiums 236,558 188,318 30,031 454,907 Unearned reinsurance commission - - 5,789 5,789 Outstanding claims 80,012 (70,881) 109,551 118,682 Claims incurred but not reported (IBNR) 43,125 156,804 11,737 211,666 Additional premium reserves 1,510 8,492 1,669 - 11,671 Other technical reserves 611 2,520 1,204 4,335 Segment liabilities 361,816 285,253 159,981 807,050 Unallocated liabilities 254,909 Total equity 338,260 Total liabilities and equity 1,400,219 26 19 SEGMENT INFORMATION (continued) As at 31 December 2021 (Audited) Property & Operating segment Medical Motor casualty Total SR (000) Assets Reinsurers' share of outstanding claims 2,685 18,221 69,224 90,130 Reinsurers' share of IBNR - - 20,802 20,802 Reinsurers' share of unearned premiums 7 - 14,480 14,487 Deferred policy acquisition costs 10,000 13,417 2,201 25,618 Segment assets 12,692 31,638 106,707 151,037 Unallocated assets 1,155,303 Total assets 1,306,340 Liabilities Unearned premiums 154,739 254,500 17,846 427,085 Unearned reinsurance commission - - 3,488 3,488 Outstanding claims 31,935 (47,348) 74,962 59,549 Claims incurred but not reported 34,377 152,484 22,249 209,110 Additional premium reserves 230 27,008 1,174 - 28,412 Other technical reserves 370 2,450 1,612 4,432 Segment liabilities 221,651 389,094 121,331 732,076 Unallocated liabilities and surplus 202,688 Total equity 371,576 Total liabilities and equity 1,306,34019 SEGMENT INFORMATION (continued) Three-months period ended 30 September 2022 (Unaudited) Property & Operating segment Medical Motor casualty Total SR (000) Revenues Gross premiums written - - - - - - -Individuals 2,178 - 95,988 - 41 - 98,207 -Very small enterprises 1,159 - 276 - - - 1,435 -Small enterprises 17,553 - 10,102 - 595 - 28,250 -Medium enterprises 24,968 - 1,911 - 5,220 - 32,099 -Corporates 74,252 - 17,151 - 10,526 - 101,929 120,110 125,428 16,382 261,920 Reinsurance premiums ceded - Local - - - - (2,111) - (2,111) - International (3) - - - (11,249) - (11,252) (3) - (13,360) (13,363)Excess of loss expenses - Local (1,579) - (206) - (151) - (1,936) - International (1,579) - (2,732) - (1,007) - (5,318) (3,158) (2,938) (1,158) (7,254)Net premiums written 116,949 122,490 1,864 241,303 Movement in unearned premiums, net (433) - (27,726) - 10 - (28,149)Net premiums earned 116,516 94,764 1,874 213,154 Reinsurance commissions - - - - 2,848 - 2,848 Other underwriting income 2,153 - 32 - 8,653 - 10,838 Net revenues 118,669 94,796 13,375 226,840 Underwriting costs and expenses Gross claims paid (65,912) - (109,080) - (420) - (175,412)Reinsurers' share of claims paid 476 - 2,890 - 329 - 3,695 Net claims paid (65,436) (106,190) (91) (171,717)Movement in outstanding claims, net (18,883) - 8,577 - (505) - (10,811)Movement in IBNR, net (1,180) - (5,370) - 2,362 - (4,188)Movement in additional premium reserve 2,194 - 7,473 - (651) - 9,016 Movement in other technical reserve (79) - (86) - 699 - 534 Net claims incurred (83,384) (95,596) 1,814 (177,166)Policy acquisition costs (8,983) - (9,260) - (2,685) - (20,928)Other underwriting expense - - (5,645) - (1) - (5,646)Total underwriting costs and expenses (92,367) (110,501) (872) (203,740)Net underwriting income / (cost) 26,302 (15,705) 12,503 23,100 Unallocated revenue 9,358 Unallocated expenses (31,463)Total income before Zakat for the period 995 28 19 SEGMENT INFORMATION (Continued) Three-months period ended 30 September 2021 (Unaudited) Property & Operating segment Medical Motor casualty Total SR (000) Revenues Gross premiums written 62,556 130,646 16,410 209,612 -Individuals 124 138,975 255 139,354 -Very small enterprises 1,483 615 7 2,105 -Small enterprises 14,568 6,761 159 21,488 -Medium enterprises 18,691 3,384 1,629 23,704 -Corporates 61,192 28,270 8,849 98,311 96,058 178,005 10,899 284,962 Reinsurance premiums ceded - Local - - (1,004) (1,004) - International (1) - (7,508) (7,509) (1) - (8,512) (8,513)Excess of loss expenses - Local (125) (98) (61) (284) - International (125) (1,242) (343) (1,710) (250) (1,340) (404) (1,994) (250) (2,198) (636) (3,084)Net premiums written 95,807 176,665 1,983 274,455 Movement in unearned premiums, net (3,980) (66,084) (126) (70,190)Net premiums earned 91,827 110,581 1,857 204,265 Reinsurance commissions - - 2,614 2,614 Other underwriting income 77 377 (19) 435 Net revenues 91,904 110,958 4,452 207,314 Underwriting costs and expenses Gross claims paid (51,623) (117,225) (3,819) (172,667)Reinsurers' share of claims paid 345 823 3,581 4,749 Net claims paid (51,278) (116,402) (238) (167,918)Movement in outstanding claims, net (5,251) 5,469 (4) 214 Movement in IBNR, net (11,183) 283 35 (10,865)Movement in additional premium reserve 2,677 (13,887) (206) (11,416)Movement in other technical reserve (128) 6 - (122)Net claims incurred (65,163) (124,531) (413) (190,107)Policy acquisition costs (6,591) (9,585) (1,820) (17,996)Other underwriting expense - (7,813) - (7,813)Total underwriting costs and expenses (71,754) (141,929) (2,233) (215,916)Net underwriting income 20,150 (30,971) 2,219 (8,602)Unallocated revenue 7,134 Unallocated expenses (31,957)Total loss before Zakat for the period (33,425)
Disclosure of comparative figures [text block]	22 COMPARATIVE FIGURES Certain comparative figures have been reclassified and regrouped to conform with the current year's presentation to these financial statements.
Disclosure of board of director's approval of the financial statements [text block]	24 APPROVAL OF INTERIM CONDENSED FINANCIAL STATEMENTS The interim condensed financial statements were approved by the Board of Directors on 12 Rabi’ al-Akhir 1444 AH corresponding to November 6, 2022.

[100010] Filing information	[200100] Independent auditors report	[300100] Statement of financial position, order of liquidity
[300200] Statement of insurance/ takaful operations, nature of expense	[300300] Statement of shareholders operations, nature of expense	[300400] Statement of other comprehensive income, before tax, insurance operations
[300500] Statement of other comprehensive income, before tax, shareholders operations	[300600] Statement of cash flows, indirect method, insurance operations	[300700] Statement of cash flows, indirect method, shareholders operations
[300800] Statement of changes in equity	[400100] Notes forming part of accounts